Zeldin Robert K 4

What Happened

• Robert K. Zeldin, Chief Medical Officer of MeiraGTx Holdings plc (MGTX), had 35,000 restricted share units (RSUs) convert into ordinary shares upon vesting on January 17, 2026. Per the filing, 13,951 of those shares were withheld to cover tax withholding at $7.42 per share, totaling $103,516. Net shares retained from this vesting event: 21,049.
• This was an award/vesting event (not an open-market purchase or voluntary sale). The withholding of shares to satisfy tax obligations is a common administrative step and not a market-sale signal.

Key Details

• Transaction date: January 17, 2026.
• Primary actions reported: conversion/vesting of 35,000 RSUs (transaction code M) and withholding of 13,951 shares for tax payment (transaction code F) at $7.42/share = $103,516.
• Net new shares retained from the vesting: 35,000 − 13,951 = 21,049.
• Footnotes: F1 — represents vesting of one-half of RSUs granted on Jan 17, 2024; F2 — each RSU converts into one ordinary share on vesting; F3 — shares were withheld to pay taxes upon vesting.
• Total shares owned after the transaction: not specified in the provided filing excerpt.

Context

• The RSU conversion (coded M) means the derivative award vested and converted into common shares; the tax withholding (coded F) is routine and typically executed by the company surrendering a portion of the vested shares to satisfy tax obligations.
• Such vesting/withholding transactions are administrative and do not by themselves indicate CEO/insider intent to buy or sell additional stock.